Skip to main content
Jenna Gallegos on Muck Rack

Jenna Gallegos

  • Freelance Contributor, Freelance
  • Director of Scientific Marketing, Director of Business Development, Samba Scientific
Fort Collins
As seen in: Daily Mail, Nature, The Washington Post, CBS News, Newsweek Europe, Chicago Tribune, NDTV, Scientific American, Stuff.co.nz, Sydney Morning Herald and
Devoted fan of food, beer, & all things science Director of Scientific Marketing @sambasci - Postdoc in #SynBio - PhD in plant #biotech
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jenna

Contact Jenna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

There’s a New Generation of Probiotics Coming to a Store Near You

|
By Jenna Gallegos
| SynBioBeta Verified
We’ve been thinking about probiotics all wrong. Typical probiotic supplements attempt to “seed” the microbiome—to shift the population of bugs in our gut in a predictable, favorable direction. The problem is, that approach just doesn’t work. Fortunately, there are a handful of biotech companies who are thinking differently. Probiotics of the future will look very different. They’ll be thoughtfully selected or engineered strains clinically proven to deliver particular benefits.
Open in Who Shared Issue with article?

Remember the “Big Data” Problem? Yeah, Me Neither

|
By Jenna Gallegos
| SynBioBeta Verified
Ten years ago, all anybody could talk about was big data. Suddenly, sequencing costs had plummeted, and there weren’t enough Python aficionados out there to analyze the mountains of sequencing data. This so-called “big data” problem was touted as the only thing standing between sequencing reads and curing cancer. At the SynBioBeta conference this year, a different problem emerged—a “small data” problem.
Open in Who Shared Issue with article?

This Single-Cell Startup Wants to Digitize the Immune System with Engineered Yeast

|
By Jenna Gallegos
| SynBioBeta Verified
We've all heard the analogies. Chopping up cells and analyzing them in bulk is like trying to pick up the taste of a single bad blueberry in a slurpy-sized fruit smoothy. Single-cell analysis is important and essential for studying rare cell populations that play important roles in cancer and immunology. But it's also expensive and technically challenging. We've also heard the phrase send a thief to catch a thief, a spy to catch a spy. Well, what if we could send a cell to catch a cell?
Open in Who Shared Issue with article?
See all 376 licensed articles (393 Total)